Business

Pharma Tycoon Faces Contempt Charges

Updated 2026-10-13 13:25 UTC 1 source Negative

Martin Shkreli, former pharmaceutical executive, faces contempt charges for violating a lifetime ban imposed after he was found guilty of organizing an illegal monopoly scheme.

Coverage timeline — 1 article

CNBC

Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.

2026-10-13 13:21 UTC